2,4,8,10-TETRAETHYL-1,7-DIMETHYL-2,4,8,10-TETRA-AZATETRACYCLO-[9.3.1.0(5,14).0(7,12)]-PENTADECANE
Compound with spectra: 1 NMR
![2,4,8,10-TETRAETHYL-1,7-DIMETHYL-2,4,8,10-TETRA-AZATETRACYCLO-[9.3.1.0(5,14).0(7,12)]-PENTADECANE](/api/compound/7Ix0SdpBy5u.png?ph=true&h=300&w=458 "2,4,8,10-TETRAETHYL-1,7-DIMETHYL-2,4,8,10-TETRA-AZATETRACYCLO-[9.3.1.0(5,14).0(7,12)]-PENTADECANE")
| SpectraBase Compound ID | 7Ix0SdpBy5u |
|---|---|
| InChI | InChI=1S/C21H40N4/c1-7-22-14-24(9-3)21(6)13-19-17-11-16(21)18(22)12-20(17,5)25(10-4)15-23(19)8-2/h16-19H,7-15H2,1-6H3/t16-,17+,18-,19-,20+,21-/m0/s1 |
| InChIKey | NAMBPCNJHDABLH-FITZOCOBSA-N |
| Mol Weight | 348.6 g/mol |
| Molecular Formula | C21H40N4 |
| Exact Mass | 348.325297 g/mol |
| Enantiomer InChIKey | NAMBPCNJHDABLH-WCAYHLDQSA-N |
| Copyright | Copyright © 2016-2024 W. Robien, Inst. of Org. Chem., Univ. of Vienna. All Rights Reserved. |
|---|---|
| Solvent | CDCl3 |
Cocaine-M (nor-BZE) TFATBDMS
CJ-16,174
benzenesulfonamide, N-(2,5-dimethoxyphenyl)-5-(4,4-dimethyl-1,1-dioxido-3-oxo-2-isothiazolidinyl)-2-methoxy-
2H-pyrido[1,2-a][1,3,5]triazine-9-carboxylic acid, 7-cyano-3-(2-ethoxyphenyl)-1,3,4,6-tetrahydro-6-thioxo-, ethyl ester
(2S,5R,1'R)-2-(2'-DIETHOXYPHOSPHORYL-2'-PHENYLETHYL)-3,6-DIETHOXY-2,5-DIHYDRO-5-ISOPROPYL-2-METHYLPYRAZINE
1a,5a,6b-1-(4-Methyl-benzoyl)-6-morpholino-bicyclo(3.1.0)hexane-6-carbonitrile
PHAKELLISTATIN_17;CYCLO-(PRO-(1)-TRP-VAL-PRO-(2)-LEU-ILE-PRO-(3)-ILE-(2))
Cocaine-M (HO-methoxy-) HFB
1R,2S,5R-Menthyl 2-benzyl-2R-methoxycartbonyl-c-5S-(1'-benzoyl-1'-ethoxycarbonylprop-3'-yl)pyrrolidine-4S-carboxylate
1-(2,4-DINITROPHENYL)-3-METHYL-5-PHENYL-4-(2,6-XYLYLAZO)PYRAZOLE
| Title | Journal or Book | Year |
|---|---|---|
| 2,3,7,8-Tetra-azatetracyclo[7.3.1.0.0]tridecanes and 2,4,6,8-tetra(alkylamino)bicyclo[3.3.1]nonanes | Journal of the Chemical Society, Perkin Transactions 1 | 1988 |